

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | phospholipid homeostasis (GO:0055091) | 4.62135093 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.09311716 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.09311716 |
| 4 | macroautophagy (GO:0016236) | 3.67860031 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 3.65884235 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.65884235 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 3.62414880 |
| 8 | protein carboxylation (GO:0018214) | 3.60431603 |
| 9 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.60431603 |
| 10 | urea cycle (GO:0000050) | 3.59312836 |
| 11 | urea metabolic process (GO:0019627) | 3.59312836 |
| 12 | complement activation, alternative pathway (GO:0006957) | 3.59229029 |
| 13 | protein localization to endosome (GO:0036010) | 3.57641661 |
| 14 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.38220643 |
| 15 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.37069739 |
| 16 | low-density lipoprotein particle clearance (GO:0034383) | 3.36850600 |
| 17 | aromatic amino acid family catabolic process (GO:0009074) | 3.35805046 |
| 18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.35421145 |
| 19 | regulation of cholesterol homeostasis (GO:2000188) | 3.33030272 |
| 20 | cholesterol efflux (GO:0033344) | 3.31713767 |
| 21 | plasma lipoprotein particle clearance (GO:0034381) | 3.31014242 |
| 22 | nitrogen cycle metabolic process (GO:0071941) | 3.28720252 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 3.28198270 |
| 24 | phospholipid efflux (GO:0033700) | 3.27568558 |
| 25 | positive regulation of p38MAPK cascade (GO:1900745) | 3.20630971 |
| 26 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.17515798 |
| 27 | regulation of protein activation cascade (GO:2000257) | 3.16711398 |
| 28 | intestinal cholesterol absorption (GO:0030299) | 3.15396249 |
| 29 | response to lipoprotein particle (GO:0055094) | 3.13615803 |
| 30 | bile acid metabolic process (GO:0008206) | 3.12669803 |
| 31 | regulation of cholesterol storage (GO:0010885) | 3.12258651 |
| 32 | bile acid biosynthetic process (GO:0006699) | 3.10656851 |
| 33 | homocysteine metabolic process (GO:0050667) | 3.09421572 |
| 34 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.04835491 |
| 35 | triglyceride homeostasis (GO:0070328) | 3.04190539 |
| 36 | acylglycerol homeostasis (GO:0055090) | 3.04190539 |
| 37 | regulation of complement activation (GO:0030449) | 3.01633416 |
| 38 | high-density lipoprotein particle remodeling (GO:0034375) | 3.01234225 |
| 39 | reverse cholesterol transport (GO:0043691) | 3.01168523 |
| 40 | desmosome organization (GO:0002934) | 3.01078477 |
| 41 | plasma lipoprotein particle assembly (GO:0034377) | 2.98949318 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 2.97076968 |
| 43 | positive regulation of sterol transport (GO:0032373) | 2.94969044 |
| 44 | positive regulation of cholesterol transport (GO:0032376) | 2.94969044 |
| 45 | positive regulation of cholesterol efflux (GO:0010875) | 2.94535447 |
| 46 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.93874612 |
| 47 | positive regulation of lipid catabolic process (GO:0050996) | 2.93334521 |
| 48 | apoptotic cell clearance (GO:0043277) | 2.92345021 |
| 49 | tryptophan metabolic process (GO:0006568) | 2.92314823 |
| 50 | lipoprotein metabolic process (GO:0042157) | 2.90513233 |
| 51 | protein-lipid complex assembly (GO:0065005) | 2.89339965 |
| 52 | amyloid precursor protein catabolic process (GO:0042987) | 2.86644806 |
| 53 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.85736765 |
| 54 | cholesterol homeostasis (GO:0042632) | 2.84744713 |
| 55 | lipoprotein transport (GO:0042953) | 2.82725429 |
| 56 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.82085455 |
| 57 | regulation of bile acid biosynthetic process (GO:0070857) | 2.81012965 |
| 58 | sterol homeostasis (GO:0055092) | 2.80127362 |
| 59 | tyrosine metabolic process (GO:0006570) | 2.79415833 |
| 60 | growth hormone receptor signaling pathway (GO:0060396) | 2.76488017 |
| 61 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.75396179 |
| 62 | myelin maintenance (GO:0043217) | 2.73823421 |
| 63 | indolalkylamine catabolic process (GO:0046218) | 2.73302214 |
| 64 | tryptophan catabolic process (GO:0006569) | 2.73302214 |
| 65 | indole-containing compound catabolic process (GO:0042436) | 2.73302214 |
| 66 | negative regulation of lipid storage (GO:0010888) | 2.71924249 |
| 67 | bile acid and bile salt transport (GO:0015721) | 2.71538186 |
| 68 | negative regulation of lipase activity (GO:0060192) | 2.70660734 |
| 69 | lipid homeostasis (GO:0055088) | 2.69051263 |
| 70 | regulation of cholesterol metabolic process (GO:0090181) | 2.68974948 |
| 71 | glucocorticoid biosynthetic process (GO:0006704) | 2.68332348 |
| 72 | mannose metabolic process (GO:0006013) | 2.67507092 |
| 73 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.67331263 |
| 74 | regulation of sequestering of triglyceride (GO:0010889) | 2.65010077 |
| 75 | regulation of protein polyubiquitination (GO:1902914) | 2.63948505 |
| 76 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.63641749 |
| 77 | valine metabolic process (GO:0006573) | 2.61458493 |
| 78 | negative regulation of fibrinolysis (GO:0051918) | 2.61421938 |
| 79 | kynurenine metabolic process (GO:0070189) | 2.60965365 |
| 80 | positive regulation of fatty acid oxidation (GO:0046321) | 2.60701354 |
| 81 | glyoxylate metabolic process (GO:0046487) | 2.59563720 |
| 82 | regulation of macrophage chemotaxis (GO:0010758) | 2.59364106 |
| 83 | regulation of fibrinolysis (GO:0051917) | 2.58691913 |
| 84 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.58216277 |
| 85 | regulation of cholesterol esterification (GO:0010872) | 2.57898238 |
| 86 | import into cell (GO:0098657) | 2.57314356 |
| 87 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.56914715 |
| 88 | ethanol oxidation (GO:0006069) | 2.56371112 |
| 89 | protein-lipid complex remodeling (GO:0034368) | 2.55297787 |
| 90 | macromolecular complex remodeling (GO:0034367) | 2.55297787 |
| 91 | plasma lipoprotein particle remodeling (GO:0034369) | 2.55297787 |
| 92 | regulation of cholesterol transport (GO:0032374) | 2.54444121 |
| 93 | regulation of sterol transport (GO:0032371) | 2.54444121 |
| 94 | sterol transport (GO:0015918) | 2.51858943 |
| 95 | cholesterol transport (GO:0030301) | 2.51858943 |
| 96 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.45771289 |
| 97 | hormone catabolic process (GO:0042447) | 2.44100533 |
| 98 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.43117705 |
| 99 | plasma lipoprotein particle organization (GO:0071827) | 2.41885768 |
| 100 | detection of molecule of bacterial origin (GO:0032490) | 2.41747241 |
| 101 | barbed-end actin filament capping (GO:0051016) | 2.41202542 |
| 102 | amino-acid betaine metabolic process (GO:0006577) | 2.40838310 |
| 103 | negative regulation of cholesterol transport (GO:0032375) | 2.40808584 |
| 104 | negative regulation of sterol transport (GO:0032372) | 2.40808584 |
| 105 | positive regulation of Rap GTPase activity (GO:0032854) | 2.40339612 |
| 106 | fatty acid transmembrane transport (GO:1902001) | 2.40031545 |
| 107 | protein-lipid complex subunit organization (GO:0071825) | 2.39987663 |
| 108 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.39621850 |
| 109 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.39609759 |
| 110 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.39348484 |
| 111 | cellular glucuronidation (GO:0052695) | 2.38939281 |
| 112 | transcytosis (GO:0045056) | 2.35808922 |
| 113 | glucocorticoid metabolic process (GO:0008211) | 2.35445302 |
| 114 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.35164243 |
| 115 | regulation of ARF protein signal transduction (GO:0032012) | 2.34837673 |
| 116 | peptide catabolic process (GO:0043171) | 2.34555488 |
| 117 | intestinal absorption (GO:0050892) | 2.33306409 |
| 118 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.32195797 |
| 119 | regulation of extracellular matrix disassembly (GO:0010715) | 2.28792132 |
| 120 | cell volume homeostasis (GO:0006884) | 2.28593276 |
| 121 | multicellular organismal water homeostasis (GO:0050891) | 2.28439129 |
| 122 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.26870318 |
| 123 | amyloid precursor protein metabolic process (GO:0042982) | 2.26270016 |
| 124 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.25551198 |
| 125 | cellular response to ethanol (GO:0071361) | 2.18755433 |
| 126 | regulation of p38MAPK cascade (GO:1900744) | 2.15815512 |
| 127 | surfactant homeostasis (GO:0043129) | 2.12951579 |
| 128 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.12112304 |
| 129 | response to laminar fluid shear stress (GO:0034616) | 2.12097921 |
| 130 | regulation of water loss via skin (GO:0033561) | 2.11351496 |
| 131 | hypotonic response (GO:0006971) | 2.08098468 |
| 132 | sodium ion export (GO:0071436) | 2.07809049 |
| 133 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.07474300 |
| 134 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.06543848 |
| 135 | establishment of endothelial barrier (GO:0061028) | 2.05884490 |
| 136 | regulation of apoptotic cell clearance (GO:2000425) | 2.04807297 |
| 137 | actin filament capping (GO:0051693) | 2.04803178 |
| 138 | negative regulation of fatty acid transport (GO:2000192) | 2.04727050 |
| 139 | glycosphingolipid catabolic process (GO:0046479) | 2.04478567 |
| 140 | adhesion of symbiont to host (GO:0044406) | 2.04080706 |
| 141 | progesterone metabolic process (GO:0042448) | 2.03928201 |
| 142 | glycosylceramide metabolic process (GO:0006677) | 2.02246369 |
| 143 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.01566504 |
| 144 | angiotensin maturation (GO:0002003) | 2.01464780 |
| 145 | positive regulation of receptor recycling (GO:0001921) | 2.01076021 |
| 146 | detection of external biotic stimulus (GO:0098581) | 1.99822704 |
| 147 | negative regulation of protein activation cascade (GO:2000258) | 1.99473493 |
| 148 | water homeostasis (GO:0030104) | 1.99469635 |
| 149 | negative regulation of erythrocyte differentiation (GO:0045647) | 1.98455420 |
| 150 | maintenance of gastrointestinal epithelium (GO:0030277) | 1.98227010 |
| 151 | negative regulation of complement activation (GO:0045916) | 1.97562607 |
| 152 | regulation of vitamin metabolic process (GO:0030656) | 1.95189269 |
| 153 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 1.94866687 |
| 154 | iron ion import (GO:0097286) | 1.92980247 |
| 155 | ovulation (GO:0030728) | 1.91772732 |
| 156 | positive regulation of steroid biosynthetic process (GO:0010893) | 1.91707783 |
| 157 | positive regulation of steroid metabolic process (GO:0045940) | 1.91019884 |
| 158 | macrophage activation involved in immune response (GO:0002281) | 1.90955099 |
| 159 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 1.90349458 |
| 160 | glucuronate metabolic process (GO:0019585) | 1.90347370 |
| 161 | uronic acid metabolic process (GO:0006063) | 1.90347370 |
| 162 | glycolipid catabolic process (GO:0019377) | 1.90322069 |
| 163 | negative regulation of humoral immune response (GO:0002921) | 1.90016851 |
| 164 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 1.89728012 |
| 165 | skin morphogenesis (GO:0043589) | 1.89660320 |
| 166 | regulation of Rap GTPase activity (GO:0032317) | 1.89375341 |
| 167 | epoxygenase P450 pathway (GO:0019373) | 1.89159021 |
| 168 | histone H3-K36 demethylation (GO:0070544) | 1.88475307 |
| 169 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 1.87257718 |
| 170 | cortical actin cytoskeleton organization (GO:0030866) | 1.87234668 |
| 171 | membrane repolarization during action potential (GO:0086011) | 1.86686032 |
| 172 | lipid translocation (GO:0034204) | 1.86431692 |
| 173 | phospholipid translocation (GO:0045332) | 1.86431692 |
| 174 | sodium ion homeostasis (GO:0055078) | 1.86070375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.80504010 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.91383429 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.79790207 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.39387807 |
| 5 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.98837607 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.81274044 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.54901022 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.53624455 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.48128252 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.35592336 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.27943784 |
| 12 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.27094148 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.12918315 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.00772339 |
| 15 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.00644747 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.94572629 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.93639123 |
| 18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.80962783 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.70584279 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.68996684 |
| 21 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.68419105 |
| 22 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.65856053 |
| 23 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.61788076 |
| 24 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.56951492 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55355408 |
| 26 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.51655179 |
| 27 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.51311104 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.50716971 |
| 29 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.45306641 |
| 30 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.45081762 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.41648725 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37034936 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36401862 |
| 34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35611951 |
| 35 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.29947352 |
| 36 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.29296104 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28925924 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28549643 |
| 39 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.28473752 |
| 40 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.28215009 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27712476 |
| 42 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.26870737 |
| 43 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.25152332 |
| 44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.25108366 |
| 45 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.24662968 |
| 46 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24641141 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24372453 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.23805709 |
| 49 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.23473732 |
| 50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22674269 |
| 51 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.21735399 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20143976 |
| 53 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17798630 |
| 54 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16519694 |
| 55 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.16137668 |
| 56 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15802138 |
| 57 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14417052 |
| 58 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.14132682 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13717790 |
| 60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13717790 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13347741 |
| 62 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.13236686 |
| 63 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12738413 |
| 64 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09869937 |
| 65 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.08759432 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08181196 |
| 67 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08105291 |
| 68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07870457 |
| 69 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07397113 |
| 70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06197411 |
| 71 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.03788673 |
| 72 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03309335 |
| 73 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02678648 |
| 74 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.02537241 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02068334 |
| 76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01050228 |
| 77 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00365963 |
| 78 | CJUN_26792858_Chip-Seq_BT549_Human | 0.99843388 |
| 79 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.99835823 |
| 80 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.99835823 |
| 81 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.99556361 |
| 82 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99453723 |
| 83 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99181655 |
| 84 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.98909675 |
| 85 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98356183 |
| 86 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.97635468 |
| 87 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.97613013 |
| 88 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.97343607 |
| 89 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97026902 |
| 90 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.96357306 |
| 91 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.95077433 |
| 92 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.94943967 |
| 93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.93068469 |
| 94 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.93068469 |
| 95 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92068657 |
| 96 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91917916 |
| 97 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91915985 |
| 98 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91609150 |
| 99 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91187527 |
| 100 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.91102090 |
| 101 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.90263359 |
| 102 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90187442 |
| 103 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.89660471 |
| 104 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.89425772 |
| 105 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89139514 |
| 106 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88721976 |
| 107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88692030 |
| 108 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.88404251 |
| 109 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88305585 |
| 110 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87621805 |
| 111 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85845009 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85653450 |
| 113 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85094939 |
| 114 | KDM2B_26808549_Chip-Seq_K562_Human | 0.83698321 |
| 115 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.83556320 |
| 116 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.83513854 |
| 117 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.83249273 |
| 118 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.83150968 |
| 119 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81293013 |
| 120 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.80700045 |
| 121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79956081 |
| 122 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.78947776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.00402364 |
| 2 | MP0005360_urolithiasis | 4.31755656 |
| 3 | MP0005365_abnormal_bile_salt | 4.27577956 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.84106615 |
| 5 | MP0000569_abnormal_digit_pigmentation | 3.68109595 |
| 6 | MP0003252_abnormal_bile_duct | 3.52707765 |
| 7 | MP0008004_abnormal_stomach_pH | 3.37511492 |
| 8 | MP0000678_abnormal_parathyroid_gland | 3.30085636 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.73090308 |
| 10 | MP0009840_abnormal_foam_cell | 2.71770844 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.66311378 |
| 12 | MP0005409_darkened_coat_color | 2.53225034 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.50224892 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.49380786 |
| 15 | MP0003195_calcinosis | 2.42323221 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.35342917 |
| 17 | MP0003303_peritoneal_inflammation | 2.35086454 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.30748799 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 2.24510339 |
| 20 | MP0002254_reproductive_system_inflammat | 2.18811041 |
| 21 | MP0002909_abnormal_adrenal_gland | 2.16801586 |
| 22 | MP0003283_abnormal_digestive_organ | 2.15840146 |
| 23 | MP0001666_abnormal_nutrient_absorption | 2.14373977 |
| 24 | MP0003724_increased_susceptibility_to | 2.11324825 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.08133619 |
| 26 | MP0005083_abnormal_biliary_tract | 2.04576656 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.95221097 |
| 28 | MP0000609_abnormal_liver_physiology | 1.83925667 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 1.81033981 |
| 30 | MP0005670_abnormal_white_adipose | 1.75354674 |
| 31 | MP0003690_abnormal_glial_cell | 1.74291260 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.61104933 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.58544522 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.56926986 |
| 35 | MP0005275_abnormal_skin_tensile | 1.55122456 |
| 36 | MP0001765_abnormal_ion_homeostasis | 1.54132848 |
| 37 | MP0002796_impaired_skin_barrier | 1.50574240 |
| 38 | MP0005166_decreased_susceptibility_to | 1.44883012 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.41296488 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.40875795 |
| 41 | MP0004130_abnormal_muscle_cell | 1.40520648 |
| 42 | MP0010234_abnormal_vibrissa_follicle | 1.39480618 |
| 43 | MP0003879_abnormal_hair_cell | 1.39278335 |
| 44 | MP0003329_amyloid_beta_deposits | 1.38910871 |
| 45 | MP0003566_abnormal_cell_adhesion | 1.38627894 |
| 46 | MP0000604_amyloidosis | 1.38404513 |
| 47 | MP0005076_abnormal_cell_differentiation | 1.38064327 |
| 48 | MP0004185_abnormal_adipocyte_glucose | 1.34689054 |
| 49 | MP0003045_fibrosis | 1.33799946 |
| 50 | MP0003866_abnormal_defecation | 1.31530025 |
| 51 | MP0005666_abnormal_adipose_tissue | 1.29848388 |
| 52 | MP0004264_abnormal_extraembryonic_tissu | 1.28776868 |
| 53 | MP0003868_abnormal_feces_composition | 1.26493000 |
| 54 | MP0000003_abnormal_adipose_tissue | 1.25672778 |
| 55 | MP0002060_abnormal_skin_morphology | 1.24157519 |
| 56 | MP0005332_abnormal_amino_acid | 1.23438720 |
| 57 | MP0009780_abnormal_chondrocyte_physiolo | 1.19635010 |
| 58 | MP0000371_diluted_coat_color | 1.17443255 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.16218275 |
| 60 | MP0005451_abnormal_body_composition | 1.15202020 |
| 61 | MP0005375_adipose_tissue_phenotype | 1.12653655 |
| 62 | MP0001661_extended_life_span | 1.11552555 |
| 63 | MP0010678_abnormal_skin_adnexa | 1.09769998 |
| 64 | MP0004019_abnormal_vitamin_homeostasis | 1.08275399 |
| 65 | MP0006082_CNS_inflammation | 1.07471844 |
| 66 | MP0009278_abnormal_bone_marrow | 1.06369933 |
| 67 | MP0005647_abnormal_sex_gland | 1.02805449 |
| 68 | MP0003453_abnormal_keratinocyte_physiol | 1.01085258 |
| 69 | MP0005408_hypopigmentation | 1.00274773 |
| 70 | MP0005319_abnormal_enzyme/_coenzyme | 1.00084197 |
| 71 | MP0002168_other_aberrant_phenotype | 0.97824217 |
| 72 | MP0000920_abnormal_myelination | 0.97107207 |
| 73 | MP0009643_abnormal_urine_homeostasis | 0.96564079 |
| 74 | MP0004510_myositis | 0.94390918 |
| 75 | MP0004947_skin_inflammation | 0.94307402 |
| 76 | MP0002006_tumorigenesis | 0.93949246 |
| 77 | MP0003436_decreased_susceptibility_to | 0.93744383 |
| 78 | MP0010307_abnormal_tumor_latency | 0.93709313 |
| 79 | MP0003091_abnormal_cell_migration | 0.92974856 |
| 80 | MP0001664_abnormal_digestion | 0.92696852 |
| 81 | MP0005164_abnormal_response_to | 0.91320059 |
| 82 | MP0005025_abnormal_response_to | 0.90374506 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 0.90139802 |
| 84 | MP0009763_increased_sensitivity_to | 0.89843859 |
| 85 | MP0005165_increased_susceptibility_to | 0.89799876 |
| 86 | MP0001851_eye_inflammation | 0.89582145 |
| 87 | MP0001873_stomach_inflammation | 0.89270037 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.88529498 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.87757139 |
| 90 | MP0005334_abnormal_fat_pad | 0.87158254 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.86630510 |
| 92 | MP0005023_abnormal_wound_healing | 0.85828293 |
| 93 | MP0002876_abnormal_thyroid_physiology | 0.85347501 |
| 94 | MP0005636_abnormal_mineral_homeostasis | 0.84559397 |
| 95 | MP0008260_abnormal_autophagy | 0.84138396 |
| 96 | MP0001845_abnormal_inflammatory_respons | 0.83391302 |
| 97 | MP0003828_pulmonary_edema | 0.82614361 |
| 98 | MP0000249_abnormal_blood_vessel | 0.82531298 |
| 99 | MP0002928_abnormal_bile_duct | 0.81721710 |
| 100 | MP0002078_abnormal_glucose_homeostasis | 0.81436020 |
| 101 | MP0005503_abnormal_tendon_morphology | 0.80336569 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.79604767 |
| 103 | MP0000598_abnormal_liver_morphology | 0.79315251 |
| 104 | MP0002098_abnormal_vibrissa_morphology | 0.78365247 |
| 105 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78235756 |
| 106 | MP0000013_abnormal_adipose_tissue | 0.76963219 |
| 107 | MP0009785_altered_susceptibility_to | 0.75901382 |
| 108 | MP0002971_abnormal_brown_adipose | 0.75849724 |
| 109 | MP0004043_abnormal_pH_regulation | 0.75172910 |
| 110 | MP0001756_abnormal_urination | 0.74786724 |
| 111 | MP0002933_joint_inflammation | 0.74773916 |
| 112 | MP0000383_abnormal_hair_follicle | 0.74635223 |
| 113 | MP0005464_abnormal_platelet_physiology | 0.74054379 |
| 114 | MP0003950_abnormal_plasma_membrane | 0.73868098 |
| 115 | MP0005220_abnormal_exocrine_pancreas | 0.73769458 |
| 116 | MP0003075_altered_response_to | 0.72909582 |
| 117 | MP0001835_abnormal_antigen_presentation | 0.72787415 |
| 118 | MP0010368_abnormal_lymphatic_system | 0.72642679 |
| 119 | MP0001533_abnormal_skeleton_physiology | 0.71479337 |
| 120 | MP0000462_abnormal_digestive_system | 0.71115699 |
| 121 | MP0001502_abnormal_circadian_rhythm | 0.70872049 |
| 122 | MP0003633_abnormal_nervous_system | 0.70862848 |
| 123 | MP0001958_emphysema | 0.70706434 |
| 124 | MP0003632_abnormal_nervous_system | 0.68572408 |
| 125 | MP0002419_abnormal_innate_immunity | 0.68327890 |
| 126 | MP0004381_abnormal_hair_follicle | 0.67491042 |
| 127 | MP0001243_abnormal_dermal_layer | 0.67473809 |
| 128 | MP0002896_abnormal_bone_mineralization | 0.67430635 |
| 129 | MP0008469_abnormal_protein_level | 0.67038228 |
| 130 | MP0004134_abnormal_chest_morphology | 0.66836633 |
| 131 | MP0002295_abnormal_pulmonary_circulatio | 0.66473170 |
| 132 | MP0002009_preneoplasia | 0.66066829 |
| 133 | MP0001663_abnormal_digestive_system | 0.65680566 |
| 134 | MP0010352_gastrointestinal_tract_polyps | 0.64681887 |
| 135 | MP0000427_abnormal_hair_cycle | 0.64608160 |
| 136 | MP0005167_abnormal_blood-brain_barrier | 0.64056567 |
| 137 | MP0005310_abnormal_salivary_gland | 0.64030454 |
| 138 | MP0000685_abnormal_immune_system | 0.63097259 |
| 139 | MP0001790_abnormal_immune_system | 0.62836325 |
| 140 | MP0005387_immune_system_phenotype | 0.62836325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 4.38440719 |
| 2 | Xanthomatosis (HP:0000991) | 3.92310042 |
| 3 | Deep venous thrombosis (HP:0002625) | 3.71763368 |
| 4 | Epidermoid cyst (HP:0200040) | 3.66425430 |
| 5 | Complement deficiency (HP:0004431) | 3.57263574 |
| 6 | Myocardial infarction (HP:0001658) | 3.50044964 |
| 7 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.38396004 |
| 8 | Tetany (HP:0001281) | 3.36858628 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 3.32723244 |
| 10 | Hyperphosphatemia (HP:0002905) | 3.30603194 |
| 11 | Malnutrition (HP:0004395) | 3.27857211 |
| 12 | Joint hemorrhage (HP:0005261) | 3.24521060 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.19322558 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.14618132 |
| 15 | Hyperactive renin-angiotensin system (HP:0000841) | 3.02229948 |
| 16 | Hypoplastic ischia (HP:0003175) | 2.97376725 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 2.95574575 |
| 18 | Abnormality of the intrinsic pathway (HP:0010989) | 2.94845773 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 2.93922308 |
| 20 | Turricephaly (HP:0000262) | 2.84355374 |
| 21 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.84163570 |
| 22 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.82545612 |
| 23 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.81195230 |
| 24 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.81195230 |
| 25 | Abnormality of glycolipid metabolism (HP:0010969) | 2.81195230 |
| 26 | Abnormality of the ischium (HP:0003174) | 2.80370043 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 2.77282904 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 2.76042387 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.63861340 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 2.62749698 |
| 31 | Abnormality of complement system (HP:0005339) | 2.57091824 |
| 32 | Dysostosis multiplex (HP:0000943) | 2.56200520 |
| 33 | Hypolipoproteinemia (HP:0010981) | 2.54063414 |
| 34 | Axonal loss (HP:0003447) | 2.54004417 |
| 35 | Cerebral aneurysm (HP:0004944) | 2.52700899 |
| 36 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.52486630 |
| 37 | Hypercholesterolemia (HP:0003124) | 2.52252022 |
| 38 | Ulnar bowing (HP:0003031) | 2.48728441 |
| 39 | Fat malabsorption (HP:0002630) | 2.48064579 |
| 40 | Systemic lupus erythematosus (HP:0002725) | 2.45753442 |
| 41 | Neurofibrillary tangles (HP:0002185) | 2.44960198 |
| 42 | Abnormality of renin-angiotensin system (HP:0000847) | 2.44467638 |
| 43 | Protuberant abdomen (HP:0001538) | 2.42169769 |
| 44 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.39820481 |
| 45 | Skin nodule (HP:0200036) | 2.39217305 |
| 46 | Hypobetalipoproteinemia (HP:0003563) | 2.31503702 |
| 47 | Hyperaldosteronism (HP:0000859) | 2.29883987 |
| 48 | Hypoglycemic seizures (HP:0002173) | 2.29245645 |
| 49 | Abnormality of chloride homeostasis (HP:0011422) | 2.24373142 |
| 50 | Hypoglycemic coma (HP:0001325) | 2.23730919 |
| 51 | Flat acetabular roof (HP:0003180) | 2.22444538 |
| 52 | Increased circulating renin level (HP:0000848) | 2.20916543 |
| 53 | Abnormality of proline metabolism (HP:0010907) | 2.19811824 |
| 54 | Hydroxyprolinuria (HP:0003080) | 2.19811824 |
| 55 | Mucopolysacchariduria (HP:0008155) | 2.18964673 |
| 56 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.18964673 |
| 57 | Increased IgE level (HP:0003212) | 2.18334502 |
| 58 | Esophageal varix (HP:0002040) | 2.17638967 |
| 59 | Thoracolumbar scoliosis (HP:0002944) | 2.14709241 |
| 60 | Alacrima (HP:0000522) | 2.12424078 |
| 61 | Hyperparathyroidism (HP:0000843) | 2.12302552 |
| 62 | Gingival bleeding (HP:0000225) | 2.11030095 |
| 63 | Autoimmune thrombocytopenia (HP:0001973) | 2.09974790 |
| 64 | Cupped ribs (HP:0000887) | 2.09769969 |
| 65 | Abnormality of macrophages (HP:0004311) | 2.09363975 |
| 66 | Ketosis (HP:0001946) | 2.08426047 |
| 67 | Increased CSF protein (HP:0002922) | 2.07312022 |
| 68 | Decreased circulating renin level (HP:0003351) | 2.07126333 |
| 69 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.06340242 |
| 70 | Interstitial pulmonary disease (HP:0006530) | 2.06328931 |
| 71 | Lip pit (HP:0100267) | 2.06236652 |
| 72 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.05568951 |
| 73 | Peripheral demyelination (HP:0011096) | 2.05524454 |
| 74 | Enlarged kidneys (HP:0000105) | 2.04763291 |
| 75 | Epiphyseal dysplasia (HP:0002656) | 2.04562212 |
| 76 | Hyporeflexia of lower limbs (HP:0002600) | 2.03767901 |
| 77 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02240103 |
| 78 | Gingivitis (HP:0000230) | 2.01717609 |
| 79 | J-shaped sella turcica (HP:0002680) | 2.01618123 |
| 80 | Abdominal distention (HP:0003270) | 2.01086933 |
| 81 | Increased cerebral lipofuscin (HP:0011813) | 2.00345725 |
| 82 | Abnormal foot bone ossification (HP:0010675) | 2.00023682 |
| 83 | Bell-shaped thorax (HP:0001591) | 1.99976263 |
| 84 | Cerebral inclusion bodies (HP:0100314) | 1.98741272 |
| 85 | Urethral obstruction (HP:0000796) | 1.98692686 |
| 86 | Glomerulonephritis (HP:0000099) | 1.98164474 |
| 87 | Right ventricular cardiomyopathy (HP:0011663) | 1.97239351 |
| 88 | Cardiovascular calcification (HP:0011915) | 1.97075152 |
| 89 | Thin bony cortex (HP:0002753) | 1.96362664 |
| 90 | Vascular calcification (HP:0004934) | 1.95427286 |
| 91 | Renal cortical cysts (HP:0000803) | 1.94984063 |
| 92 | Elevated alkaline phosphatase (HP:0003155) | 1.94482234 |
| 93 | Abnormality of methionine metabolism (HP:0010901) | 1.94163845 |
| 94 | Amyloidosis (HP:0011034) | 1.93115853 |
| 95 | Hyperglycemia (HP:0003074) | 1.93056336 |
| 96 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.92483205 |
| 97 | Hematochezia (HP:0002573) | 1.92478657 |
| 98 | Congenital sensorineural hearing impairment (HP:0008527) | 1.91794264 |
| 99 | Increased connective tissue (HP:0009025) | 1.91095940 |
| 100 | Visceral angiomatosis (HP:0100761) | 1.90376991 |
| 101 | Metaphyseal irregularity (HP:0003025) | 1.89247181 |
| 102 | Abnormal tarsal ossification (HP:0008369) | 1.87105970 |
| 103 | Hypophosphatemia (HP:0002148) | 1.86689671 |
| 104 | Hypochromic microcytic anemia (HP:0004840) | 1.86608298 |
| 105 | Onion bulb formation (HP:0003383) | 1.86105131 |
| 106 | Abnormality of the periventricular white matter (HP:0002518) | 1.85665789 |
| 107 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.85652517 |
| 108 | Absent frontal sinuses (HP:0002688) | 1.85368202 |
| 109 | Metaphyseal cupping (HP:0003021) | 1.85304276 |
| 110 | Scanning speech (HP:0002168) | 1.84864283 |
| 111 | Thick nail (HP:0001805) | 1.84355370 |
| 112 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84138635 |
| 113 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.83340483 |
| 114 | Alopecia of scalp (HP:0002293) | 1.83139215 |
| 115 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.82948971 |
| 116 | Mixed hearing impairment (HP:0000410) | 1.82710768 |
| 117 | Hypoplasia of dental enamel (HP:0006297) | 1.82299398 |
| 118 | Loss of speech (HP:0002371) | 1.81767080 |
| 119 | Tubulointerstitial nephritis (HP:0001970) | 1.81214039 |
| 120 | Aneurysm (HP:0002617) | 1.80412567 |
| 121 | Metabolic alkalosis (HP:0200114) | 1.79880558 |
| 122 | Ventricular fibrillation (HP:0001663) | 1.79534137 |
| 123 | Periodontitis (HP:0000704) | 1.79343520 |
| 124 | Hyperkalemia (HP:0002153) | 1.78065031 |
| 125 | Hemorrhage of the eye (HP:0011885) | 1.77926800 |
| 126 | Abnormality of purine metabolism (HP:0004352) | 1.77662779 |
| 127 | Broad face (HP:0000283) | 1.76073001 |
| 128 | Thoracic kyphosis (HP:0002942) | 1.75803131 |
| 129 | Mitral stenosis (HP:0001718) | 1.75370862 |
| 130 | Macroorchidism (HP:0000053) | 1.74389040 |
| 131 | Nephritis (HP:0000123) | 1.74350843 |
| 132 | Tibial bowing (HP:0002982) | 1.74207382 |
| 133 | Heterotopia (HP:0002282) | 1.73974218 |
| 134 | Tetraparesis (HP:0002273) | 1.73467012 |
| 135 | Symptomatic seizures (HP:0011145) | 1.73415896 |
| 136 | Hyperglycinuria (HP:0003108) | 1.73405539 |
| 137 | Steatorrhea (HP:0002570) | 1.73056788 |
| 138 | Hepatocellular carcinoma (HP:0001402) | 1.72029472 |
| 139 | Renal salt wasting (HP:0000127) | 1.71046374 |
| 140 | Hemangiomatosis (HP:0007461) | 1.69697879 |
| 141 | Coarse hair (HP:0002208) | 1.68544951 |
| 142 | Dysmetric saccades (HP:0000641) | 1.65747362 |
| 143 | Hypocalcemia (HP:0002901) | 1.64752428 |
| 144 | Abnormality of the fingertips (HP:0001211) | 1.64288632 |
| 145 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.64276934 |
| 146 | Aplasia of the phalanges of the hand (HP:0009802) | 1.64276934 |
| 147 | Aplasia involving bones of the extremities (HP:0009825) | 1.64276934 |
| 148 | Obstructive sleep apnea (HP:0002870) | 1.63647072 |
| 149 | Sensorimotor neuropathy (HP:0007141) | 1.63471417 |
| 150 | Osteolytic defects of the hand bones (HP:0009699) | 1.62569310 |
| 151 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.62569310 |
| 152 | Bone pain (HP:0002653) | 1.62082045 |
| 153 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.61844328 |
| 154 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.61844328 |
| 155 | Stridor (HP:0010307) | 1.61222888 |
| 156 | Slow saccadic eye movements (HP:0000514) | 1.61085040 |
| 157 | Decreased lacrimation (HP:0000633) | 1.60784117 |
| 158 | Recurrent bacterial skin infections (HP:0005406) | 1.60583627 |
| 159 | Hypotension (HP:0002615) | 1.59912635 |
| 160 | Abnormality of the nasal mucosa (HP:0000433) | 1.58990586 |
| 161 | Adrenal overactivity (HP:0002717) | 1.58648398 |
| 162 | Abnormal glucose tolerance (HP:0001952) | 1.58510166 |
| 163 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.56834870 |
| 164 | Colitis (HP:0002583) | 1.56293566 |
| 165 | Rickets (HP:0002748) | 1.56109235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK1 | 2.93564630 |
| 2 | TAOK3 | 2.88327387 |
| 3 | RIPK1 | 2.81749933 |
| 4 | PRPF4B | 2.79646290 |
| 5 | INSRR | 2.79393156 |
| 6 | CAMK1D | 2.61395897 |
| 7 | CDK12 | 2.44579976 |
| 8 | FRK | 2.41809383 |
| 9 | CAMK1G | 2.31623638 |
| 10 | EPHB1 | 2.25384381 |
| 11 | PTK6 | 2.08455861 |
| 12 | FGFR4 | 2.01200869 |
| 13 | LATS1 | 1.97033845 |
| 14 | JAK1 | 1.81485649 |
| 15 | MAP3K14 | 1.74707592 |
| 16 | MET | 1.62297783 |
| 17 | TYK2 | 1.62183792 |
| 18 | FGFR2 | 1.61572306 |
| 19 | PINK1 | 1.59773252 |
| 20 | EPHA3 | 1.57291486 |
| 21 | TTN | 1.55804632 |
| 22 | TRIB3 | 1.51362697 |
| 23 | MAP3K1 | 1.38504287 |
| 24 | PDGFRB | 1.35003632 |
| 25 | FER | 1.33227639 |
| 26 | ERN1 | 1.32341713 |
| 27 | BLK | 1.28396608 |
| 28 | WNK1 | 1.28265421 |
| 29 | STK24 | 1.27871950 |
| 30 | PTK2 | 1.27285273 |
| 31 | NLK | 1.24413495 |
| 32 | FGFR3 | 1.21638609 |
| 33 | MAP3K3 | 1.18445949 |
| 34 | MAP3K2 | 1.18346354 |
| 35 | STK39 | 1.16465967 |
| 36 | PDGFRA | 1.15557240 |
| 37 | PKN1 | 1.15482100 |
| 38 | STK38 | 1.14974702 |
| 39 | CDK6 | 1.14737989 |
| 40 | DDR2 | 1.13767537 |
| 41 | MTOR | 1.12420218 |
| 42 | SGK3 | 1.10059582 |
| 43 | STK3 | 1.07372632 |
| 44 | PDK2 | 1.06738682 |
| 45 | ZAP70 | 1.05124898 |
| 46 | MAP3K10 | 1.04894898 |
| 47 | JAK2 | 1.04491577 |
| 48 | ACVR1B | 1.03982490 |
| 49 | MAP3K13 | 1.03792169 |
| 50 | AKT3 | 1.03759747 |
| 51 | LMTK2 | 0.99430601 |
| 52 | JAK3 | 0.98134926 |
| 53 | NEK6 | 0.97059136 |
| 54 | CHUK | 0.96362446 |
| 55 | GSK3A | 0.93890474 |
| 56 | DAPK2 | 0.93775463 |
| 57 | EPHA2 | 0.93537256 |
| 58 | IRAK3 | 0.91649275 |
| 59 | PRKD3 | 0.91552802 |
| 60 | MST1R | 0.88592321 |
| 61 | TGFBR2 | 0.87926828 |
| 62 | DMPK | 0.87166427 |
| 63 | RIPK4 | 0.85878797 |
| 64 | MAP3K7 | 0.84193582 |
| 65 | NUAK1 | 0.82628184 |
| 66 | FGR | 0.82442387 |
| 67 | PRKAA2 | 0.82033678 |
| 68 | ERBB4 | 0.81595914 |
| 69 | IRAK1 | 0.80347577 |
| 70 | CSF1R | 0.79749390 |
| 71 | IKBKE | 0.78233791 |
| 72 | ZAK | 0.77911113 |
| 73 | PDPK1 | 0.77175907 |
| 74 | CSK | 0.76578695 |
| 75 | STK4 | 0.76142358 |
| 76 | PRKAA1 | 0.74968672 |
| 77 | BRD4 | 0.74680728 |
| 78 | TAOK2 | 0.73837190 |
| 79 | PRKCH | 0.73745166 |
| 80 | MAP4K1 | 0.73630952 |
| 81 | MELK | 0.73436906 |
| 82 | NTRK1 | 0.73255487 |
| 83 | BCKDK | 0.72692856 |
| 84 | PRKD1 | 0.72279413 |
| 85 | ERBB2 | 0.70021627 |
| 86 | PIK3CA | 0.69401870 |
| 87 | TAOK1 | 0.69276897 |
| 88 | CDC42BPA | 0.66715364 |
| 89 | IKBKB | 0.66458123 |
| 90 | ICK | 0.66148778 |
| 91 | PKN2 | 0.66104851 |
| 92 | SMG1 | 0.65690572 |
| 93 | STK10 | 0.65476362 |
| 94 | MAPK12 | 0.64888676 |
| 95 | PDK1 | 0.64453431 |
| 96 | TRPM7 | 0.64054092 |
| 97 | BMX | 0.63078058 |
| 98 | SGK223 | 0.62898346 |
| 99 | SGK494 | 0.62898346 |
| 100 | MARK2 | 0.62513106 |
| 101 | SIK2 | 0.62166695 |
| 102 | PAK3 | 0.62106811 |
| 103 | PIK3CG | 0.61899071 |
| 104 | MST4 | 0.61855269 |
| 105 | HIPK2 | 0.61746693 |
| 106 | EEF2K | 0.61634904 |
| 107 | RET | 0.61384974 |
| 108 | SGK2 | 0.60729785 |
| 109 | KIT | 0.58923290 |
| 110 | MAPK15 | 0.56768540 |
| 111 | FLT3 | 0.55823434 |
| 112 | TBK1 | 0.55090301 |
| 113 | SGK1 | 0.53781260 |
| 114 | OXSR1 | 0.52619292 |
| 115 | NTRK3 | 0.52433335 |
| 116 | PTK2B | 0.51775490 |
| 117 | PRKCQ | 0.50725213 |
| 118 | MAPK7 | 0.49991969 |
| 119 | MAPK11 | 0.49733592 |
| 120 | MAP2K3 | 0.48491746 |
| 121 | MAP2K6 | 0.47529001 |
| 122 | ITK | 0.46940632 |
| 123 | NEK9 | 0.44188446 |
| 124 | KSR2 | 0.42929495 |
| 125 | PRKG2 | 0.42516202 |
| 126 | HCK | 0.42011094 |
| 127 | MAP2K2 | 0.41576334 |
| 128 | YES1 | 0.41545821 |
| 129 | PAK2 | 0.41454783 |
| 130 | BMPR2 | 0.41250444 |
| 131 | MATK | 0.40671656 |
| 132 | CDK9 | 0.40511711 |
| 133 | PRKD2 | 0.40277825 |
| 134 | INSR | 0.40054643 |
| 135 | TNK2 | 0.38775033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.63668235 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.07271552 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.32588469 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.30573045 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.18311318 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.15590556 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.99607999 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.95278493 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.93640299 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.92060278 |
| 11 | ABC transporters_Homo sapiens_hsa02010 | 1.88698041 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88142021 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.79630904 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.75334045 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.68731196 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.61797540 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.61417859 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.59386255 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.58487347 |
| 20 | Lysine degradation_Homo sapiens_hsa00310 | 1.57622947 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.42766965 |
| 22 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41405785 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.40689790 |
| 24 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.37950206 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.35839599 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.27929142 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.24929255 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.24036076 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.22115360 |
| 30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19586667 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.19403732 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.17841452 |
| 33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.17572808 |
| 34 | Insulin resistance_Homo sapiens_hsa04931 | 1.17213820 |
| 35 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.14838064 |
| 36 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.14566594 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14207897 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.08008331 |
| 39 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.05703601 |
| 40 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.04520081 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.02070593 |
| 42 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.01722324 |
| 43 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.01574597 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.00821358 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00551488 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.00331461 |
| 47 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.95125944 |
| 48 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94166925 |
| 49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93341380 |
| 50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91008481 |
| 51 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90139202 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88412374 |
| 53 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.88286687 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 0.83588091 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81386996 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81183049 |
| 57 | Leishmaniasis_Homo sapiens_hsa05140 | 0.79256042 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78993388 |
| 59 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.77283653 |
| 60 | Tight junction_Homo sapiens_hsa04530 | 0.74969895 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.74895719 |
| 62 | Renin secretion_Homo sapiens_hsa04924 | 0.74493180 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74102521 |
| 64 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.73084994 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.72797570 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71847363 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71730790 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.71171832 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70421923 |
| 70 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.70159677 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70060232 |
| 72 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69100735 |
| 73 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.67070145 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66927786 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64158956 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63113202 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62291874 |
| 78 | Tuberculosis_Homo sapiens_hsa05152 | 0.60979549 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60874634 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60365201 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60164982 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59400532 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.59271373 |
| 84 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.58362152 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57287571 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56563727 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55755146 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.55170007 |
| 89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54683037 |
| 90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54615373 |
| 91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53996479 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.53986685 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53795635 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50683140 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.50439475 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49951980 |
| 97 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49910280 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48783816 |
| 99 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.48494857 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48216108 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.48169684 |
| 102 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.44888209 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.42261691 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | 0.41949559 |
| 105 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.41365943 |
| 106 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40725928 |
| 107 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.40698139 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39974595 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38901968 |
| 110 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37928113 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37441652 |
| 112 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.36882781 |
| 113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36157494 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.35534391 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34682495 |
| 116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30372199 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30070906 |
| 118 | Malaria_Homo sapiens_hsa05144 | 0.29556452 |
| 119 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29070986 |
| 120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28569262 |
| 121 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.28523375 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27731119 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.27662486 |
| 124 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.27660864 |
| 125 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.27134931 |
| 126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26886648 |
| 127 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.25564193 |
| 128 | Hepatitis C_Homo sapiens_hsa05160 | 0.25338481 |
| 129 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.23746734 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.23608631 |
| 131 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.23175630 |
| 132 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.22073155 |
| 133 | Prostate cancer_Homo sapiens_hsa05215 | 0.21379470 |
| 134 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.21103242 |
| 135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20357743 |
| 136 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.20030100 |

